Integrated health technology assessment for evaluating complex technologies
The rise of complex, chronic diseases in an ageing European population led to the development of increasingly complex technologies. Current HTA is not well equipped to assess complex technologies due to a lack of attention to the...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
IMPACT HTA
Improved Methods and Actionable Tools for Enhancing Health T...
5M€
Cerrado
UBIHEALTH
Exchange of Excellence in Ubiquitous Computing Technologies...
815K€
Cerrado
SELFIE
Sustainable intEgrated care modeLs for multi morbidity deli...
5M€
Cerrado
RTC-2016-5609-1
Simulación de itinerarios de atención de pacientes crónicos...
264K€
Cerrado
CSO2014-54490-R
DESARROLLO DE HERRAMIENTAS PARA LA MEJORA DE LA GESTION Y ES...
50K€
Cerrado
Dynamic CER
Dynamic Comparative Effectiveness Research for health care i...
185K€
Cerrado
Información proyecto INTEGRATE-HTA
Líder del proyecto
UNIVERSITAET BREMEN
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The rise of complex, chronic diseases in an ageing European population led to the development of increasingly complex technologies. Current HTA is not well equipped to assess complex technologies due to a lack of attention to the diversity in patient characteristics and patient preferences, the limited consideration of context and implementation issues, and missing strategies to integrate all these aspects into a comprehensive assessment.
We shall develop concepts and methods for HTA to enable a patient-centered, integrated assessment of the effectiveness, and the economic, social, cultural and ethical issues of complex technologies that takes context and implementation into account. We shall use palliative care for our case study as it is of extremely high relevance and it is an excellent example for a highly complex technology.
More specifically, we shall adapt and develop methods and concepts
- to assess the effectiveness and economic, social, cultural, and ethical issues of complex technologies,
- to elicit patient preferences and patient-specific moderators of treatment
- to include context, setting, and implementation
- and, finally, to integrate these issues into a patient-centered, comprehensive assessment of complex technologies.
Concepts and methods will be tested through assessing the complex technology Specialist palliative care. Revised guidance will be issued for comment to all relevant stakeholders.
All partners of the consortium have an outstanding track record in the development of HTA methodology and are actively involved in major international initiatives in the field. The project will complement the work of similar initiatives and projects on HTA development, especially EUNetHTA/EUNetHTA JA and inform HTA agencies in all European countries. By focusing on an integrated assessment, we shall also match the need of policy-makers who prefer this to dealing with scattered information on innovative and complex technologies.